# Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-for-local-action/c75f03a9-fe74-43cb-90de-ab8a4cbbd770

> FDA guidance document: Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. Issue date: April 03, 2003. Get complete insights and analysis.

---

## Details

- Title: Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2003-04-03
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-0050">FDA-1999-D-0050</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Data Integrity for In Vivo Bioavailability and Bioequivalence Studies](https://www.globalkeysolutions.net/guidances/guidance-document/data-integrity-for-in-vivo-bioavailability-and-bioequivalence-studies/04d979b3-3f1d-4515-b9c1-f1a8fb7fb19b)
- [Applications Covered by Section 505(b)(2)](https://www.globalkeysolutions.net/guidances/guidance-document/applications-covered-by-section-505b2/5f0df47f-0a4f-498e-9b76-34682f4067f5)